Thanks to Mamapop funding, researchers in Lleida have been able to identify genetic variation schemes in patients with ERBB-2 positive breast cancer, a finding that will improve the treatment of these patients by offering them a more personalised option. The research was recently published …

Research by IRBLleida and the UdL lays the foundations for possible future combined therapies by identifying a death pathway in tumour cells Glioblastoma is the most common and aggressive brain cancer, due to its ability to evade the immune system and grow. The Calcium …